Business Description
We Can Medicines Co Ltd
ISIN : TW0006929003
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.12 | |||||
Debt-to-EBITDA | 4.02 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 1.8 | |||||
Beneish M-Score | -2.66 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.8 | |||||
3-Year EBITDA Growth Rate | -1.2 | |||||
3-Year EPS without NRI Growth Rate | -38.4 | |||||
3-Year FCF Growth Rate | 24.6 | |||||
3-Year Book Growth Rate | 0.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.91 | |||||
9-Day RSI | 32.3 | |||||
14-Day RSI | 31.52 | |||||
6-1 Month Momentum % | -41.43 | |||||
12-1 Month Momentum % | -63.46 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.63 | |||||
Quick Ratio | 0.68 | |||||
Cash Ratio | 0.27 | |||||
Days Inventory | 138.58 | |||||
Days Sales Outstanding | 26.08 | |||||
Days Payable | 89.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.72 | |||||
Forward Dividend Yield % | 0.72 | |||||
5-Year Yield-on-Cost % | 0.72 | |||||
3-Year Average Share Buyback Ratio | -7.6 | |||||
Shareholder Yield % | -30.5 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.04 | |||||
Operating Margin % | -0.31 | |||||
Net Margin % | -0.23 | |||||
FCF Margin % | 3.08 | |||||
ROE % | -0.74 | |||||
ROA % | -0.24 | |||||
ROIC % | -0.51 | |||||
ROC (Joel Greenblatt) % | 1.03 | |||||
ROCE % | 1.01 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 80.71 | |||||
PS Ratio | 0.49 | |||||
PB Ratio | 1.43 | |||||
Price-to-Tangible-Book | 1.44 | |||||
Price-to-Free-Cash-Flow | 16.01 | |||||
Price-to-Operating-Cash-Flow | 9.09 | |||||
EV-to-EBIT | 129.34 | |||||
EV-to-EBITDA | 8.39 | |||||
EV-to-Revenue | 0.83 | |||||
EV-to-FCF | 26.87 | |||||
Earnings Yield (Greenblatt) % | 0.77 | |||||
FCF Yield % | 6.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
We Can Medicines Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 3,266.764 | ||
EPS (TTM) (NT$) | -0.15 | ||
Beta | 0 | ||
Volatility % | 23.83 | ||
14-Day RSI | 31.52 | ||
14-Day ATR (NT$) | 0.473715 | ||
20-Day SMA (NT$) | 38.155 | ||
12-1 Month Momentum % | -63.46 | ||
52-Week Range (NT$) | 37 - 117.5 | ||
Shares Outstanding (Mil) | 44.27 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
We Can Medicines Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
We Can Medicines Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
We Can Medicines Co Ltd Frequently Asked Questions
What is We Can Medicines Co Ltd(ROCO:6929)'s stock price today?
When is next earnings date of We Can Medicines Co Ltd(ROCO:6929)?
Does We Can Medicines Co Ltd(ROCO:6929) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |